Detralex, 1000 mg/10 ml suspension 10 ml sachet 15 pcs

Detralex® has venotonic and angioprotective properties. The drug reduces venous distensibility and venous stasis, reduces capillary permeability and increases their resistance. The results of clinical studies confirm the pharmacological activity of the drug with respect to the parameters of venous hemodynamics.

Indications

Detralex® is indicated for therapy of symptoms of chronic venous diseases (elimination and relief of symptoms).
Therapy of symptoms of venous and lymphatic insufficiency:
– pain;
– cramps of the lower extremities;
– feeling of heaviness and tautness in the legs;
– “tired” legs.
Therapy of manifestations of venous-lymphatic insufficiency:
– edema of the lower extremities;
– trophic changes in the skin and subcutaneous tissue;
– venous trophic ulcers.
Symptomatic therapy of acute and chronic hemorrhoids.

Active ingredient

Purified micronized flavonoid fraction (diosmin, flavonoids in terms of hesperidin)

How to take, the dosage

The drug is taken orally.

Interaction

Drug interaction of the drug Detralex® has not been reported.

Special Instructions

Before starting to use the drug Detralex®, the patient is advised to consult a doctor.

Contraindications

– Hypersensitivity to the active ingredient or excipients that make up the drug;
– fructose intolerance.
It is not recommended to administer the drug to nursing women.

Side effects

The side effects of the drug Detralex® observed during clinical trials were mild in severity.

Overdose

No cases of overdose have been described.

Similarities

Venarus, Phlebaven, Venolife Duo, Detravenol, Diosmin+Hesperidin, Troxactiv